IL94377A - Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them - Google Patents

Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them

Info

Publication number
IL94377A
IL94377A IL9437790A IL9437790A IL94377A IL 94377 A IL94377 A IL 94377A IL 9437790 A IL9437790 A IL 9437790A IL 9437790 A IL9437790 A IL 9437790A IL 94377 A IL94377 A IL 94377A
Authority
IL
Israel
Prior art keywords
antagonize
effects
amino acids
pharmaceutical compositions
excitatory amino
Prior art date
Application number
IL9437790A
Other languages
English (en)
Other versions
IL94377A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL94377A0 publication Critical patent/IL94377A0/xx
Publication of IL94377A publication Critical patent/IL94377A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9437790A 1989-05-16 1990-05-14 Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them IL94377A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (2)

Publication Number Publication Date
IL94377A0 IL94377A0 (en) 1991-03-10
IL94377A true IL94377A (en) 1997-01-10

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9437790A IL94377A (en) 1989-05-16 1990-05-14 Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them

Country Status (19)

Country Link
EP (1) EP0398283B1 (fi)
JP (1) JP3014001B2 (fi)
KR (1) KR0169107B1 (fi)
CN (1) CN1027369C (fi)
AT (1) ATE113597T1 (fi)
AU (1) AU626418B2 (fi)
DE (1) DE69013750T2 (fi)
DK (1) DK0398283T3 (fi)
ES (1) ES2066035T3 (fi)
FI (1) FI95795C (fi)
GR (1) GR3014893T3 (fi)
HU (1) HU214322B (fi)
IE (1) IE64671B1 (fi)
IL (1) IL94377A (fi)
NO (1) NO177141C (fi)
NZ (1) NZ233641A (fi)
PT (1) PT94042B (fi)
TW (1) TW207950B (fi)
ZA (1) ZA903588B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
WO1992015565A1 (en) * 1991-02-27 1992-09-17 Merrell Dow Pharmaceuticals Inc. Nmda antagonists
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
US6787534B2 (en) * 1999-12-28 2004-09-07 Eisai Co., Ltd. Sulfonamide-containing heterocyclic compounds
MXPA03008291A (es) * 2001-03-14 2003-12-11 Gr Nenthal Gmbh Pirazolopirimidinas y tiazolopirimidinas sustituidas.
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
JP5592348B2 (ja) 2008-04-11 2014-09-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ａｍｐにより活性化されたプロテインキナーゼ（ａｍｐｋ）アクチベーターとしてのチエノピリドン誘導体
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
IE901750L (en) 1990-11-16
GR3014893T3 (en) 1995-05-31
HUT54657A (en) 1991-03-28
JPH0311067A (ja) 1991-01-18
KR0169107B1 (ko) 1999-01-15
HU214322B (hu) 1998-03-02
AU5491490A (en) 1990-11-22
TW207950B (fi) 1993-06-21
PT94042A (pt) 1991-01-08
IL94377A0 (en) 1991-03-10
JP3014001B2 (ja) 2000-02-28
KR900018112A (ko) 1990-12-20
NZ233641A (en) 1992-07-28
NO177141C (no) 1995-07-26
ES2066035T3 (es) 1995-03-01
DE69013750T2 (de) 1995-05-24
NO177141B (no) 1995-04-18
NO902179L (no) 1990-11-19
EP0398283B1 (en) 1994-11-02
IE64671B1 (en) 1995-08-23
FI95795C (fi) 1996-03-25
HU903031D0 (en) 1990-09-28
ATE113597T1 (de) 1994-11-15
AU626418B2 (en) 1992-07-30
NO902179D0 (no) 1990-05-15
EP0398283A1 (en) 1990-11-22
PT94042B (pt) 1997-05-28
FI95795B (fi) 1995-12-15
CN1047292A (zh) 1990-11-28
FI902416A0 (fi) 1990-05-15
ZA903588B (en) 1991-02-27
DE69013750D1 (de) 1994-12-08
CN1027369C (zh) 1995-01-11
DK0398283T3 (da) 1994-11-28

Similar Documents

Publication Publication Date Title
IL94377A (en) Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them
ZA902928B (en) Excitatory amino acid antagonists
IL93325A0 (en) Isoquinoline derivatives,process for their preparation and pharmaceutical compositions containing them
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
HUT67237A (en) Excitatory amino acid antagonists indole derivatives, their preparation and pharmaceutical compositions comprising them
AU5696094A (en) Hydroxyiminoalkylindole carboxylic acid derivatives used as antagonists of excitatory amino acids
EP0432994A3 (en) Excitatory amino acid antagonists as anti-emetic drugs
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
HUT67301A (en) Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising them
NZ227880A (en) Pyridyl substituted 1,3 dioxane alkenoic acid derivatives and pharmaceutical compositions
NZ238124A (en) Heterocyclylalkylphosphonic acid and ester derivatives and pharmacueitcal compositions
IT1231723B (it) Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
EP0639197A1 (en) EXCITING AMINO ACID ANTAGONISTS.
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
LV5790B4 (lv) Difosfonskabes atvasinajumu farmaceitiskas kompozicijas
IT8019354A0 (it) Derivati dell'acido nicotinico adattivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.